These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1177 related items for PubMed ID: 25886386

  • 1. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS, Xiong F, Xie XH, Chen D, Pan JH, Cheng L.
    BMC Nephrol; 2015 Mar 31; 16():44. PubMed ID: 25886386
    [Abstract] [Full Text] [Related]

  • 2. Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats.
    Ju Y, Su Y, Chen Q, Ma K, Ji T, Wang Z, Li W, Li W.
    Biomed Pharmacother; 2019 Jan 31; 109():84-92. PubMed ID: 30396095
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.
    Guo H, Wang Y, Zhang X, Zang Y, Zhang Y, Wang L, Wang H, Wang Y, Cao A, Peng W.
    Sci Rep; 2017 Jul 31; 7(1):6852. PubMed ID: 28761152
    [Abstract] [Full Text] [Related]

  • 7. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
    Fan Y, Fan H, Zhu B, Zhou Y, Liu Q, Li P.
    BMC Complement Altern Med; 2019 Dec 05; 19(1):355. PubMed ID: 31805910
    [Abstract] [Full Text] [Related]

  • 8. Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway.
    Lei X, Zhang BD, Ren JG, Luo FL.
    Life Sci; 2018 Aug 01; 206():77-83. PubMed ID: 29792879
    [Abstract] [Full Text] [Related]

  • 9. Grape seed proanthocyanidins protect against streptozotocin‑induced diabetic nephropathy by attenuating endoplasmic reticulum stress‑induced apoptosis.
    Gao Z, Liu G, Hu Z, Shi W, Chen B, Zou P, Li X.
    Mol Med Rep; 2018 Aug 01; 18(2):1447-1454. PubMed ID: 29901130
    [Abstract] [Full Text] [Related]

  • 10. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
    Chen J, Hou XF, Wang G, Zhong QX, Liu Y, Qiu HH, Yang N, Gu JF, Wang CF, Zhang L, Song J, Huang LQ, Jia XB, Zhang MH, Feng L.
    J Ethnopharmacol; 2016 Dec 04; 193():433-444. PubMed ID: 27664441
    [Abstract] [Full Text] [Related]

  • 11. Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats.
    Lei X, Zhang L, Li Z, Ren J.
    Drug Des Devel Ther; 2018 Dec 04; 12():2785-2793. PubMed ID: 30233141
    [Abstract] [Full Text] [Related]

  • 12. Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway.
    Sun DL, Guo ZY, Liu WY, Zhang L, Zhang ZY, Hu YL, Li SF, Zhang MY, Zhang G, Wang JJ, Fang JA.
    Chin J Integr Med; 2024 Jul 23. PubMed ID: 39039342
    [Abstract] [Full Text] [Related]

  • 13. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression.
    Gui D, Huang J, Guo Y, Chen J, Chen Y, Xiao W, Liu X, Wang N.
    Cytokine; 2013 Mar 23; 61(3):970-7. PubMed ID: 23434274
    [Abstract] [Full Text] [Related]

  • 14. Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation.
    Zhang Y, Tao C, Xuan C, Jiang J, Cao W.
    Oxid Med Cell Longev; 2020 Mar 23; 2020():9542165. PubMed ID: 32855769
    [Abstract] [Full Text] [Related]

  • 15. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.
    Luo ZF, Feng B, Mu J, Qi W, Zeng W, Guo YH, Pang Q, Ye ZL, Liu L, Yuan FH.
    Toxicol Appl Pharmacol; 2010 Jul 23; 246(1-2):49-57. PubMed ID: 20399799
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of resveratrol on kidney in rats with diabetic nephropathy and its effect on endoplasmic reticulum stress.
    Yuan D, Liu XM, Fang Z, Du LL, Chang J, Lin SH.
    Eur Rev Med Pharmacol Sci; 2018 Mar 23; 22(5):1485-1493. PubMed ID: 29565511
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
    Ge J, Miao JJ, Sun XY, Yu JY.
    J Ethnopharmacol; 2016 Aug 02; 189():238-49. PubMed ID: 27224243
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
    Zhang C, Li Q, Lai S, Yang L, Shi G, Wang Q, Luo Z, Zhao R, Yu Y.
    J Ethnopharmacol; 2017 Jun 09; 205():207-216. PubMed ID: 28501426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.